SCHEMBL2230016

SCHEMBL2230016

CC(=O)Nc1cccc2cc(OCCC3CCN(C(=O)OCc4cscn4)CC3)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MET P08581 1/20 0.37
GRIN2B Q13224 5/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CASP3 P42574 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
CASP6 P55212 1/20 0.36
TGFBR1 P36897 1/20 0.36
MAPT P10636 1/20 0.35
GPR119 Q8TDV5 3/20 0.35
CCR8 P51685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230429 0.85 LMNA (0.47) GRIN2BKDM4EPOLBLMNAHTT
SCHEMBL2229045 0.85 MMP2 (0.45) MMP2MMP9METGRIN2BNPC1
SCHEMBL2226607 0.85 MMP2 (0.43) MMP2MMP9GRIN2BKDM4EPOLB
SCHEMBL2227230 0.83 GRIN2B (0.44) MMP2MMP9GRIN2BKDM4ENPC1
SCHEMBL2227489 0.82 MMP2 (0.42) MMP2MMP9METGRIN2BGPR119
SCHEMBL2228401 0.81 MAPT (0.47) MMP2MMP9GRIN2BKDM4ENPC1
SCHEMBL2229024 0.81 GRIN2B (0.42) MMP2MMP9GRIN2BKDM4EALDH1A1
SCHEMBL2228170 0.79 MMP2 (0.47) MMP2MMP9GRIN2BLMNARAB9A
SCHEMBL2365563 0.79 MMP2 (0.40) MMP2MMP9METGRIN2BGPR119
SCHEMBL2228462 0.79 MMP2 (0.40) MMP2MMP9GRIN2BGPR119CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US claimed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP claimed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US claimed
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO claimed
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US disclosed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION PRMT9, PRMT8, CBR1 MMP2 2880/4885MMP9 522/4885MET 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.